Clinical Trials in Philadelphia

Showing 20121-20140 of 20,904 trials

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

NCT00120393

Patients with HIV who are virologically suppressed on a lopinavir/ritonavir combination highly active antiretroviral therapy (HAART) regimen but with elevated non-HDL cholesterol are randomized to remain on lopinavir/ritonavir or change to atazanavir/ritonavir in combination with current nucleoside reverse transcriptase inhibitors (NRTIs).

HIV Infections

Bristol-Myers Squibb192 participantsStarted Jan 2004

Phoenix, Arizona, United States • Bakersfield, California, United States • Los Angeles, California, United States +11 more locations

COMPLETEDPhase 3< 1 mile

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

NCT00135395

The purpose of this study is to compare the anti-HIV efficacy, safety and effect of serum lipids of two boosted protease inhibitor-based HAART regimens (ARV/RTV v. LPV/RTV) in HIV-1 infected subjects who have experienced their first virologic failure while receiving a NNRTI-containing HAART regimen.

HIV Infections

Bristol-Myers Squibb200 participantsStarted May 2004

Hobson City, Alabama, United States • Montgomery, Alabama, United States • Phoenix, Arizona, United States +50 more locations

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

Find Trials by Condition in Philadelphia

Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

The Safety and Efficacy of Low and High Carbohydrate Diets

Quality of Life in Pediatric Inflammatory Bowel Disease

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Minimally Invasive Surgical Therapy for BPH

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis

Safety and Efficacy Evaluation of Erbium Treatment

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis